• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRRK2 通过调节 CPT1A 促进 HepG2 细胞的β-氧化。

LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells.

机构信息

Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan.

Department of Animal Science and Technology, National Taiwan University, Taipei 106, Taiwan.

出版信息

Molecules. 2020 Sep 9;25(18):4122. doi: 10.3390/molecules25184122.

DOI:10.3390/molecules25184122
PMID:32916992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7570678/
Abstract

Leucine-rich repeat kinase 2 (LRRK2) is involved in lipid metabolism; however, the role of LRRK2 in lipid metabolism to affect non-alcoholic fatty liver disease (NAFLD) is still unclear. In the mouse model of NAFLD induced by a high-fat diet, we observed that LRRK2 was decreased in livers. In HepG2 cells, exposure to palmitic acid (PA) down-regulated LRRK2. Overexpression and knockdown of LRRK2 in HepG2 cells were performed to further investigate the roles of LRRK2 in lipid metabolism. Our results showed that β-oxidation in HepG2 cells was promoted by LRRK2 overexpression, whereas LRRK2 knockdown inhibited β-oxidation. The critical enzyme of β-oxidation, carnitine palmitoyltransferase 1A (CPT1A), was positively regulated by LRRK2. Our data suggested that the regulation of CPT1A by LRRK2 may be via the activation of AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor α (PPARα). The overexpression of LRRK2 reduced the concentration of a pro-inflammatory cytokine, tumor necrosis factor α (TNFα), induced by PA. The increase in β-oxidation may promote lipid catabolism to suppress inflammation induced by PA. These results indicated that LRRK2 participated in the regulation of β-oxidation and suggested that the decreased LRRK2 may promote inflammation by suppressing β-oxidation in the liver.

摘要

富含亮氨酸重复激酶 2(LRRK2)参与脂质代谢;然而,LRRK2 在脂质代谢中影响非酒精性脂肪性肝病(NAFLD)的作用尚不清楚。在高脂肪饮食诱导的 NAFLD 小鼠模型中,我们观察到肝脏中 LRRK2 减少。在 HepG2 细胞中,棕榈酸(PA)暴露下调了 LRRK2。在 HepG2 细胞中过表达和敲低 LRRK2 以进一步研究 LRRK2 在脂质代谢中的作用。我们的结果表明,LRRK2 过表达促进了 HepG2 细胞中的β-氧化,而 LRRK2 敲低抑制了β-氧化。β-氧化的关键酶肉碱棕榈酰转移酶 1A(CPT1A)受 LRRK2 正向调节。我们的数据表明,LRRK2 通过激活 AMP 激活的蛋白激酶(AMPK)和过氧化物酶体增殖物激活受体α(PPARα)来调节 CPT1A。LRRK2 的过表达降低了 PA 诱导的促炎细胞因子肿瘤坏死因子α(TNFα)的浓度。β-氧化的增加可能促进脂质分解代谢,从而抑制 PA 诱导的炎症。这些结果表明 LRRK2 参与了β-氧化的调节,并表明肝脏中 LRRK2 的减少可能通过抑制β-氧化来促进炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/02ca2b3ca051/molecules-25-04122-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/24a43ca1b71b/molecules-25-04122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/fd9f237531f8/molecules-25-04122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/0e366f18ac3a/molecules-25-04122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/20ad0bf54e0f/molecules-25-04122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/728db201cbf4/molecules-25-04122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/02ca2b3ca051/molecules-25-04122-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/24a43ca1b71b/molecules-25-04122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/fd9f237531f8/molecules-25-04122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/0e366f18ac3a/molecules-25-04122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/20ad0bf54e0f/molecules-25-04122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/728db201cbf4/molecules-25-04122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43b4/7570678/02ca2b3ca051/molecules-25-04122-g006.jpg

相似文献

1
LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells.LRRK2 通过调节 CPT1A 促进 HepG2 细胞的β-氧化。
Molecules. 2020 Sep 9;25(18):4122. doi: 10.3390/molecules25184122.
2
LB100 ameliorates nonalcoholic fatty liver disease the AMPK/Sirt1 pathway.LB100 通过 AMPK/Sirt1 通路改善非酒精性脂肪性肝病。
World J Gastroenterol. 2019 Dec 7;25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607.
3
ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.ACACA 通过 AMPK-PPARα-CPT1A 轴双重调节脂质代谢和线粒体功能来减少脂质积累。
J Transl Med. 2024 Feb 23;22(1):196. doi: 10.1186/s12967-024-04942-0.
4
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.泽泻醇A 24-乙酸酯预防HepG2细胞中的肝脂肪变性和代谢紊乱。
Cell Physiol Biochem. 2016;40(3-4):453-464. doi: 10.1159/000452560. Epub 2016 Nov 25.
5
Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.下调 microRNA-375 通过靶向非酒精性脂肪性肝病中的 AdipoR2 调节脂肪因子并抑制炎症细胞因子。
Clin Exp Pharmacol Physiol. 2018 Aug;45(8):819-831. doi: 10.1111/1440-1681.12940. Epub 2018 Apr 30.
6
Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.芦丁通过降低肝脏脂质水平和减轻脂质诱导的氧化损伤,在非酒精性脂肪性肝病小鼠模型中表现出肝脏保护作用。
Int Immunopharmacol. 2017 Aug;49:132-141. doi: 10.1016/j.intimp.2017.05.026. Epub 2017 Jun 1.
7
Mangiferin Improved Palmitate-Induced-Insulin Resistance by Promoting Free Fatty Acid Metabolism in HepG2 and C2C12 Cells via PPAR: Mangiferin Improved Insulin Resistance.芒果苷通过促进 PPAR 改善棕榈酸诱导的 HepG2 和 C2C12 细胞游离脂肪酸代谢来改善胰岛素抵抗:芒果苷改善胰岛素抵抗。
J Diabetes Res. 2019 Jan 27;2019:2052675. doi: 10.1155/2019/2052675. eCollection 2019.
8
Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.非酒精性脂肪性肝炎中微小RNA-451的下调通过AMPK/AKT途径抑制脂肪酸诱导的促炎细胞因子产生。
Int J Biochem Cell Biol. 2015 Jul;64:265-76. doi: 10.1016/j.biocel.2015.04.016. Epub 2015 May 7.
9
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
10
IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.IGFBP5 通过激活 AMPK 通路在非酒精性脂肪肝病中调节脂代谢和胰岛素敏感性。
Life Sci. 2020 Sep 1;256:117997. doi: 10.1016/j.lfs.2020.117997. Epub 2020 Jun 22.

引用本文的文献

1
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis.基于转录组分析的代谢功能障碍相关脂肪性肝病的分子聚类
Diagnostics (Basel). 2025 Jan 31;15(3):342. doi: 10.3390/diagnostics15030342.
2
Assays to enhance metabolic phenotyping in the kidney.增强肾脏代谢表型分析的检测方法。
Am J Physiol Renal Physiol. 2025 Apr 1;328(4):F563-F577. doi: 10.1152/ajprenal.00232.2024. Epub 2025 Jan 17.
3
TIGAR exacerbates obesity by triggering LRRK2-mediated defects in macroautophagy and chaperone-mediated autophagy in adipocytes.

本文引用的文献

1
Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease.抑制神经酰胺合成可减轻非酒精性脂肪性肝病大鼠的肝脂肪变性和纤维化。
Front Endocrinol (Lausanne). 2019 Sep 26;10:665. doi: 10.3389/fendo.2019.00665. eCollection 2019.
2
Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease.线粒体在非酒精性脂肪性肝病中的作用的分子见解。
Arch Pharm Res. 2019 Nov;42(11):935-946. doi: 10.1007/s12272-019-01178-1. Epub 2019 Sep 30.
3
The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms.
TIGAR 通过触发脂肪细胞中 LRRK2 介导的巨自噬和伴侣介导的自噬缺陷来加剧肥胖。
Autophagy. 2024 Aug;20(8):1741-1761. doi: 10.1080/15548627.2024.2338576. Epub 2024 Apr 30.
4
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development.线粒体肉碱棕榈酰转移酶1A:结构、功能及药物开发基础的见解
Front Pharmacol. 2023 Mar 23;14:1160440. doi: 10.3389/fphar.2023.1160440. eCollection 2023.
5
Changes in Liver Lipidomic Profile in G2019S- Mouse Model of Parkinson's Disease.G2019S 突变型帕金森病小鼠模型中肝脏脂质组学谱的变化。
Cells. 2023 Mar 4;12(5):806. doi: 10.3390/cells12050806.
6
The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression.HSF1-CPT1a 通路在非酒精性脂肪性肝病进展中受到差异调节。
Cells. 2022 Nov 4;11(21):3504. doi: 10.3390/cells11213504.
7
LRRK2 and Lipid Pathways: Implications for Parkinson's Disease.LRRK2 与脂质代谢通路:帕金森病的相关影响。
Biomolecules. 2022 Oct 30;12(11):1597. doi: 10.3390/biom12111597.
8
Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy?肉碱棕榈酰转移酶系统:抗炎和抗癌治疗的新靶点?
Front Pharmacol. 2021 Oct 26;12:760581. doi: 10.3389/fphar.2021.760581. eCollection 2021.
9
Parkinson's Disease-Related Genes and Lipid Alteration.帕金森病相关基因与脂质改变。
Int J Mol Sci. 2021 Jul 16;22(14):7630. doi: 10.3390/ijms22147630.
10
The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression.肉碱棕榈酰转移酶(CPTs)在脂肪酸氧化和癌症进展中的作用及治疗意义。
Am J Cancer Res. 2021 Jun 15;11(6):2477-2494. eCollection 2021.
棕榈酸对巨噬细胞炎症反应的影响:分子机制概述。
Inflamm Res. 2019 Nov;68(11):915-932. doi: 10.1007/s00011-019-01273-5. Epub 2019 Jul 30.
4
Rab GTPases as Physiological Substrates of LRRK2 Kinase.作为LRRK2激酶生理底物的Rab GTP酶
Exp Neurobiol. 2019 Apr;28(2):134-145. doi: 10.5607/en.2019.28.2.134. Epub 2019 Apr 30.
5
Is Parkinson's disease a chronic low-grade inflammatory bowel disease?帕金森病是一种慢性低度炎症性肠病吗?
J Neurol. 2020 Aug;267(8):2207-2213. doi: 10.1007/s00415-019-09321-0. Epub 2019 Apr 12.
6
LRRK2 links genetic and sporadic Parkinson's disease.LRRK2 将遗传性和散发性帕金森病联系起来。
Biochem Soc Trans. 2019 Apr 30;47(2):651-661. doi: 10.1042/BST20180462. Epub 2019 Mar 5.
7
Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression.罗米地辛通过上调细胞因子信号转导抑制因子 1 的表达抑制单钠尿酸盐晶体诱导的细胞因子产生。
Arthritis Res Ther. 2019 Feb 6;21(1):50. doi: 10.1186/s13075-019-1834-x.
8
The Distinct Effects of Palmitic and Oleic Acid on Pancreatic Beta Cell Function: The Elucidation of Associated Mechanisms and Effector Molecules.棕榈酸和油酸对胰腺β细胞功能的不同影响:相关机制及效应分子的阐释
Front Pharmacol. 2019 Jan 21;9:1554. doi: 10.3389/fphar.2018.01554. eCollection 2018.
9
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4.富含亮氨酸重复激酶 2 通过磷酸二酯酶 4 控制蛋白激酶 A 的激活状态。
J Neuroinflammation. 2018 Oct 27;15(1):297. doi: 10.1186/s12974-018-1337-8.
10
Rosiglitazone ameliorates palmitic acid-induced cytotoxicity in TM4 Sertoli cells.罗格列酮可改善棕榈酸诱导的 TM4 支持细胞的细胞毒性。
Reprod Biol Endocrinol. 2018 Oct 17;16(1):98. doi: 10.1186/s12958-018-0416-0.